SI Septerna, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)No insider purchase over the last 90 days. The latest was filed 10 Mar 2025.
Follow the Septerna, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was reported on 1 October 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Bhatt Elizabeth. Every trade is free.
Since the insiders bought Filed 10 Mar 2025 · 572 days ago · €85,531
+293.9%
Entry US$6.68 · Close at T+365 US$26.31
Filed 27 Feb 2025 · 583 days ago · €33,568
+348.5%
Entry US$6.47 · Close at T+365 US$29.02
Filed 27 Feb 2025 · 583 days ago · €54,262
+348.5%
Entry US$6.47 · Close at T+365 US$29.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 October 2026
All Executives44 Thresholds0 Prospectus0 Other0
Declarations 44 total
● Officer · Executives · 1 Oct 2026
10,001 shares @ US$39.13 Common SEC144:0001950047-26-009973
● Officer · Executives · 1 Oct 2026
12,592 shares @ US$39.13 Common SEC144:0001950047-26-009949
◇ SVP, Drug Discovery · Executives · 1 Sept 2026
3,333 shares @ US$2.76 0.0005% mcap 2.8% of flow Common Stock SEC:0001193125-26-382267:0
▼ SVP, Drug Discovery · Executives · 1 Sept 2026
3,333 shares @ US$37.8271 0.0069% mcap 38.9% of flow Common Stock SEC:0001193125-26-382267:1
▼ Director · Executives · 12 Aug 2026
746,500 shares @ US$42.50 Common Stock SEC:0001231919-26-000938:1
▼ Director · Executives · 12 Aug 2026
746,500 shares @ US$42.50 1.74% mcap 100.0% of flow Common Stock SEC:0001231919-26-000938:0
▼ 10% Owner · Executives · 12 Aug 2026
141 shares @ US$51.08 0.0004% mcap 0.0% of flow Common Stock SEC:0001193125-26-352692:1
▼ 10% Owner · Executives · 12 Aug 2026
147,059 shares @ US$50.27 0.41% mcap 49.6% of flow Common Stock SEC:0001193125-26-352692:0
◇ President and COO · Executives · 11 Aug 2026
18,681 shares @ US$6.81 0.0070% mcap 8.2% of flow Common Stock SEC:0001193125-26-349810:0
◇ President and COO · Executives · 11 Aug 2026
6,319 shares @ US$2.76 0.0010% mcap 1.1% of flow Common Stock SEC:0001193125-26-349810:1
▼ President and COO · Executives · 11 Aug 2026
25,000 shares @ US$44.00 0.060% mcap 70.6% of flow Common Stock SEC:0001193125-26-349810:2
● Affiliate · Executives · 12 Aug 2026
746,500 shares @ US$48.19 1.98% mcap 100.0% of flow Common SEC144:0001178937-26-000041
● 10% Stockholder · Executives · 12 Aug 2026
147,200 shares @ US$51.00 0.41% mcap 50.4% of flow Common SEC144:0001974078-26-000301
● affiliate · Executives · 12 Aug 2026
746,500 shares @ US$48.19 1.98% mcap 100.0% of flow Common SEC144:0001178937-26-000042
● Officer · Executives · 11 Aug 2026
29,000 shares @ US$38.85 0.062% mcap 89.0% of flow Common SEC144:0001950047-26-007956
◇ SVP, Drug Discovery · Executives · 3 Aug 2026
1,816 shares @ US$2.76 0.0003% mcap 1.6% of flow Common Stock SEC:0001193125-26-335820:0
◇ SVP, Drug Discovery · Executives · 3 Aug 2026
1,518 shares @ US$2.76 0.0002% mcap 1.3% of flow Common Stock SEC:0001193125-26-335820:1
▼ SVP, Drug Discovery · Executives · 3 Aug 2026
1,000 shares @ US$33.9756 0.0019% mcap 10.6% of flow Common Stock SEC:0001193125-26-335820:2
▼ SVP, Drug Discovery · Executives · 3 Aug 2026
2,334 shares @ US$34.6805 0.0045% mcap 25.2% of flow Common Stock SEC:0001193125-26-335820:3
◇ President and COO · Executives · 15 Jul 2026
4,000 shares @ US$6.81 0.0015% mcap 1.8% of flow Common Stock SEC:0001193125-26-308073:0
▼ President and COO · Executives · 15 Jul 2026
4,000 shares @ US$33.9935 0.0075% mcap 8.8% of flow Common Stock SEC:0001193125-26-308073:1
● Officer · Executives · 15 Jul 2026
4,000 shares @ US$34.54 0.0077% mcap 11.0% of flow Common SEC144:0001950047-26-007101
● Officer · Executives · 26 Jun 2026
2,438 shares @ US$36.605 0.0053% mcap 2.6% of flow Common SEC144:0001950047-26-006526
● Officer · Executives · 22 Jun 2026
94,339 shares @ US$35.2571 0.20% mcap 97.4% of flow Common SEC144:0001950047-26-006351
● Officer · Executives · 22 Jun 2026
25,000 shares @ US$36.17 0.056% mcap 100.0% of flow Common SEC144:0001950047-26-006361
25 of 44 declarations
Load more (19 remaining) About Septerna, Inc. Septerna, Inc. is a company listed on the XNAS market. It specializes in developing innovative solutions in the biotechnology sector.
Recent ranked signals on the same market Purchases our model currently ranks for the recommendations list.
All recommendations